Clinical trial for the effect of improving physical function by chiropractic care, or combination of chiropractic care and dietary supplement or physical therapy in healthy Japanese subjects: a parallel-group comparison study

Clinical trial for the effect of improving physical function by chiropractic care, or combination of chiropractic care and dietary supplement or physical therapy in healthy Japanese subjects: a parallel-group comparison study - Clinical trial for the effect of improving physical function by chiropractic care, or combination of chiropractic care and dietary supplement or physical therapy in healthy Japanese subjects

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000047900

Enrollment

Registered

2022-05-31

Start date

2022-05-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese subjects

Interventions

Duration: Four weeks Intervention: Nothing care Duration: Four weeks Intervention: Only chiropractic care Duration: Four weeks Intervention: Chiropractic care + taking dietary supplements (CALFAMIL

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Japanese 2. Men or women 3. Subjects aged between 20 and 60 4. Healthy subjects 5. Subjects who have not undergone chiropractic care (for at least one year) 6. Subjects who are judged as eligible to participate in the study by the physician

Exclusion criteria

Exclusion criteria: 1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, stroke disorder, dyslipidemia, hypertension, neoplastic disease, hemorrhagic disease, infectious disease, amyotrophy, heart disease, disc herniation, ossification of the posterior longitudinal ligament, spondylosis deformans, spinal stenosis, osteoporosis, atlantoaxial subluxation, unstable spine, scoliosis, spina bifida, spondylolisthesis, or any other chronic diseases 4. Subjects who take "Foods for Specified Health Uses," "Foods with Functional Claims," or other functional food/beverage in daily use 5. Subjects who currently taking medications (including herbal medicines) and supplements 6. Subjects who are allergic to medicines and/or the test food related products 7. Subjects who are pregnant, lactation, or planning to become pregnant 8. Subjects who suffer from COVID-19 9. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 10. Subjects who are smokers 11. Subjects who are judged as ineligible to participate in the study by the physician

Design outcomes

Primary

Measure	Time frame
Questionnaires and medical record	—

Secondary

Measure	Time frame
Blood test, moisture of the skin, and postural distortion	—

Countries

Japan

Contacts

Public ContactHiromitsu Nakatsu

Nihontyokuhan Souhonsya Co.,Ltd. Corporate strategy division

nakatsu_hiromitsu@zenkenkai.jp03-3356-0621

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026